Study Stopped
Product unavailability
Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Blood transfusion is nearly always needed during open heart surgery in children less than 15 kg (35 pounds). The purpose of the red blood cells in the blood is to deliver oxygen to the organs and tissues of the body. Stored blood undergoes some changes that may make it less effective in achieving this goal. The purpose of this study is to see if restoring important energy molecules (ATP and 2,3,DPG) in stored red blood cells before they are transfused, with a rejuvenating solution (Rejuvesol), offers any advantages to children over standard blood transfusion. This is a Food and Drug Administration (FDA) approved process that is described by the American Association of Blood Banks for prolonging blood storage but not used for everyday transfusions. The investigators want to use this process to improve blood transfused to children undergoing heart surgery. Although Rejuvesol has been previously approved by the FDA, it is not routinely used to prepare standard blood transfusions to children undergoing surgery. Use of Rejuvesol in this study is considered investigational. This is a pilot study and data will be collected for future protocol development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2020
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2015
CompletedFirst Posted
Study publicly available on registry
June 30, 2015
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedApril 27, 2020
April 1, 2020
1 year
June 26, 2015
April 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in tissue oxygenation/perfusion during cardiac surgery, measured by whole blood lactate concentration
End of Surgery
Change in ischemic organ injury during cardiac surgery, measured by urinary neutrophil gelatinase associated lipocalin (NGAL)
2 hours
Change in hemolysis during cardiac surgery, as measured by plasma free hemoglobin levels
end of bypass
Study Arms (1)
Rejuvenated PRBCs
EXPERIMENTALThe investigators will restore important energy molecules in stored red blood cells before they are transfused, with a rejuvenating solution (Rejuvesol).
Interventions
The study interventions will take place during a routine admission for pediatric open heart surgery. The anesthetic technique for subjects undergoing cardiac surgery is standard care and the research study interventions will not change these practices in any way.
Eligibility Criteria
You may qualify if:
- children greater than 2.5 kg and less than 15kg (i.e. requiring blood for CPB prime)
- children undergoing cardiac surgery with cardiopulmonary bypass
You may not qualify if:
- refusal of blood products
- end-stage renal disease
- planned avoidance of CPB
- use of non- heparin anticoagulants
- participation in an experimental drug or device protocol within 30 days
- existing hemoglobinopathy
- allergy requiring washed RBCs
- immunocompromise requiring special blood product treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Univerisity Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Lodge, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2015
First Posted
June 30, 2015
Study Start
June 1, 2020
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
April 27, 2020
Record last verified: 2020-04